{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:50:02Z","timestamp":1776451802790,"version":"3.51.2"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":3717,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1093\/bja\/aem232","type":"journal-article","created":{"date-parts":[[2007,8,6]],"date-time":"2007-08-06T20:13:58Z","timestamp":1186431238000},"page":"572-575","source":"Crossref","is-referenced-by-count":63,"title":["Sublingual oxybutynin reduces postoperative pain related to indwelling bladder catheter after radical retropubic prostatectomy \u2020"],"prefix":"10.1016","volume":"99","author":[{"given":"P.","family":"Tauzin-Fin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sesay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Svartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-C.","family":"Krol-Houdek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Maurette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/bja\/aem232_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/bja\/75.2.132","article-title":"Visceral pain","volume":"75","author":"McMahon","year":"1995","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aem232_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0094-0143(02)00175-1","article-title":"Practical considerations in radical retropubic prostatectomy","volume":"30","author":"Lepor","year":"2003","journal-title":"Urol Clin North Am"},{"key":"10.1093\/bja\/aem232_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1469-445X.1999.tb00083.x","article-title":"Advances in the pharmacological control of the bladder","volume":"14","author":"Andersson","year":"1999","journal-title":"Exp Physiol"},{"key":"10.1093\/bja\/aem232_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0025-6196(11)62382-3","article-title":"Prospective randomized controlled trial of extended release oxybutybin chloride and tolterodine in the treatmentof over active bladder: results of the OBJECT study","volume":"76","author":"Appell","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1093\/bja\/aem232_bib5","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1213\/01.ane.0000167775.46192.e9","article-title":"The efficacy of tolterodine for prevention of catheter related bladder discomfort: a prospective randomized placebo-controlled double blind study","volume":"101","author":"Agarwal","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aem232_bib6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1017\/S0265021506001062","article-title":"Intravenous magnesium sulphate decreases postoperative tramadol requirement after radical prostatectomy","volume":"23","author":"Tauzin-Fin","year":"2006","journal-title":"Eur J Anesthesiol"},{"key":"10.1093\/bja\/aem232_bib7","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1213\/01.ANE.0000152010.74739.B8","article-title":"Postoperative gabapentine decreases anxienty and improves early functionnal recovery from knee surgery","volume":"100","author":"Merigaux","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aem232_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/00003495-199958050-00002","article-title":"Balanced analgesia: what is it and what are its advantages in postoperative pain","volume":"58","author":"Kehlet","year":"1999","journal-title":"Drugs"},{"key":"10.1093\/bja\/aem232_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s003450100226","article-title":"Which muscarinic receptor is important in the bladder","volume":"19","author":"Yamanishi","year":"2001","journal-title":"World J Urol"},{"key":"10.1093\/bja\/aem232_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0090-4295(99)00493-8","article-title":"Functional role of M1, M2 and M3 muscarinic receptors in overactive bladder","volume":"55","author":"Igawa","year":"2000","journal-title":"Urology"},{"key":"10.1093\/bja\/aem232_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-4295(99)00492-6","article-title":"Muscarinic receptor antagonists in the treatment of overactive bladder","volume":"55","author":"Chapple","year":"2000","journal-title":"Urology"},{"key":"10.1093\/bja\/aem232_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/bja\/ael003","article-title":"Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter bladder discomfort: a prospective, randomized, placebo controlled double-blind study","volume":"96","author":"Agarwal","year":"2006","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aem232_bib13","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2165\/00003495-200565090-00003","article-title":"Pharmacological management of acute agitation","volume":"65","author":"Battaglia","year":"2005","journal-title":"Drugs"},{"key":"10.1093\/bja\/aem232_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-199506030-00007","article-title":"Oxybutynin: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability","volume":"6","author":"Yarker","year":"1995","journal-title":"Drugs Aging"},{"key":"10.1093\/bja\/aem232_bib15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0022-5347(01)65148-6","article-title":"Comparison of oxybutynin and its active metabolite N-desethyl-oxybutynin in the human detrusor and parotid gland","volume":"157","author":"Waldeck","year":"1997","journal-title":"J Urol"},{"key":"10.1093\/bja\/aem232_bib16","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1517\/14656566.4.12.2315","article-title":"Transdermal oxybutynin: a new treatment for over active bladder","volume":"4","author":"Davila","year":"2003","journal-title":"Expert Opin Pharmacother"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217354788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217354788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bja\/article-pdf\/99\/4\/572\/864734\/aem232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T06:22:42Z","timestamp":1546669362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091217354788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0007091217354788"],"URL":"https:\/\/doi.org\/10.1093\/bja\/aem232","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}